The Command trial enrolled six patients and will test the safety and efficacy of the Synchron Switch motor neuroprosthesis in patients with severe paralysis, according to a Sept. 5 Synchron news release.
For the patients who cannot use their hands, the study will assess how brain-computer interface technology will allow them to complete tasks such as emailing, online shopping and telehealth services with their thoughts.
The research is being conducted under an investigational device exemption awarded to the company by the FDA.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
